Borrelia afzelii
Borrelia afzelii is a bacterial species belonging to the Borrelia genus, which is known for causing various forms of Lyme disease. This particular species is primarily found in Europe and Asia, and is transmitted to humans through the bite of an infected tick.
Taxonomy
The genus Borrelia is part of the larger family of Spirochaetaceae, which includes other pathogenic species. Borrelia afzelii was named after the Swedish scientist, Arvid Afzelius, who first described the skin rash now known as Erythema migrans, a common symptom of Lyme disease.
Transmission and Disease
Borrelia afzelii is transmitted through the bite of an infected tick, specifically the Ixodes ricinus species, also known as the castor bean tick. Once in the human body, the bacteria can cause Lyme disease, which manifests in several stages. The early localized stage is characterized by flu-like symptoms and a distinctive skin rash known as Erythema migrans. If left untreated, the disease can progress to more serious stages, affecting the joints, heart, and nervous system.
Diagnosis and Treatment
Diagnosis of Borrelia afzelii infection is typically based on clinical symptoms and a history of possible exposure to infected ticks. Laboratory testing can be used to confirm the diagnosis. Treatment usually involves a course of antibiotics, such as doxycycline or amoxicillin. Early treatment is crucial to prevent the disease from progressing to later stages.
Prevention
Prevention of Borrelia afzelii infection primarily involves avoiding tick bites through the use of insect repellents, wearing protective clothing, and checking for ticks after spending time in wooded or grassy areas. In areas where Borrelia afzelii is prevalent, public health measures may also include controlling the tick population.
See Also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

